| Medius AG - FLUAD, Injektionssuspension | | 58317 | | 13 | | FLUAD | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 24.08.2019 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) mind.15 µg et neuraminidasum inactivatum (Virus-Stamm A/Brisbane/02/2018 (H1N1)-like: reassortant virus IVR-190 derived from A/Brisbane/02/2018), haemagglutininum influenzae A (H3N2) mind.15 µg et neuraminidasum inactivatum (Virus-Stamm A/Kansas/14/2017 (H3N2)-like: reassortant virus X-327 derived from A/Kansas/14/2017), haemagglutininum influenzae B mind.15 µg et neuraminidasum inactivatum (Virus-Stamm B/Colorado/06/2017)-like: reassortant virus B/Victoria/2/87_B/Maryland/15/2016), adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, residui: ovalbuminum, barii sulfas, kanamycini monosulfas, neomycini sulfas, formaldehydum, cetrimidum, hydrocortisonum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | | | | Principe actif |
|---|
| .15 Μg et Neuraminidasum Inactivatum (Virus-Stamm A/brisbane/02/2018 (H1N1)-Like: Reassortant Virus Ivr-190 Derived from A/brisbane/02/2018) | | Haemagglutininum Influenzae a (H1N1) Mind | | Haemagglutininum Influenzae a (H3N2) Mind | | Haemagglutininum Influenzae b mind.15 Μg et Neuraminidasum Inactivatum (Virus-Stamm B/colorado/06/2017)-like: Reassortant Virus B/victoria/2/87_b/maryland/15/2016) |
| | | | Agents auxilliaires | | informations additionels |
|---|
| .15 Μg et Neuraminidasum Inactivatum (Virus-Stamm A/kansas/14/2017 (H3N2)-Like: Reassortant Virus X-327 Derived from A/kansas/14/2017) | | | | Acide Citrique | | | | Barii Sulfas | | | | Calcium Chlorure | | | | Cetrimide | | | | Disodium Phosphate Dihydrate | | | | Formaldehydum | | | | Hydrocortisone | | | | Potassium Chlorure | | | | Potassium Dihydrogenophosphate | | | | Kanamycine Monosulfate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chlorure | | excipiens | | Natrii Citras Dihydricus | | | | Neomycine Sulfate | | | | Ovalbuminum | | residui | | Polysorbatum 80 | | | | Sorbitani Trioleas | | | | Squalenum | | adjuvans MF59 |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
